Panagora Asset Management Inc Sarepta Therapeutics, Inc. Transaction History

Panagora Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$65.97 - $92.48 $88,465 - $124,015	-1,341 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$69.38 - $86.75 $226,525 - $283,238	-3,265 Reduced 70.89%	1,341 $104,000
Q1 2021 May 12, 2021	BUY	$72.25 - $168.95 $131,278 - $306,982	1,817 Added 65.15%	4,606 $343,000
Q4 2020 Feb 10, 2021	SELL	$125.56 - $178.74 $297,451 - $423,435	-2,369 Reduced 45.93%	2,789 $475,000
Q3 2020 Nov 13, 2020	BUY	$127.12 - $172.34 $34,576 - $46,876	272 Added 5.57%	5,158 $724,000
Q2 2020 Aug 12, 2020	BUY	$93.0 - $171.7 $377,580 - $697,102	4,060 Added 491.53%	4,886 $783,000
Q1 2020 May 14, 2020	BUY	$82.38 - $131.64 $68,045 - $108,734	826 New	826 $81,000
Q3 2019 Nov 12, 2019	SELL	$72.81 - $156.91 $5,096 - $10,983	-70 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$115.31 - $161.51 $8,071 - $11,305	70 New	70 $11,000

528

83.9M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.3B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.